High cholesterol and elevated triglycerides are not just a cardiology problem — they are often a metabolic and hormonal one. Dr. Marie Noelle Kallas Chemaly addresses lipid imbalances at their endocrine root.
Book a ConsultationMost patients with dyslipidemia are managed in primary care or cardiology. But when cholesterol stays high despite medication, when triglycerides remain stubbornly elevated, or when lipid abnormalities appear alongside diabetes, thyroid dysfunction, obesity, or PCOS — the underlying driver is often hormonal.
As an endocrinologist, Dr. Kallas Chemaly evaluates lipid disorders in the context of the full metabolic picture: insulin resistance, thyroid function, adrenal status, and hormonal balance. Treating cholesterol in isolation misses the mechanism. Treating the mechanism changes outcomes.
Conditions managed include:
Hypothyroidism is one of the most common — and most overlooked — causes of elevated LDL cholesterol. Treating the thyroid often corrects the lipid panel without additional medication. Dr. Kallas Chemaly screens for this connection routinely.
Type 2 diabetes and insulin resistance reliably disrupt lipid metabolism — elevating triglycerides and lowering HDL. Lipid management is inseparable from diabetes care in her practice.
Women with PCOS face elevated cardiovascular risk partly through dyslipidemia. Hormonal correction and targeted lipid management are part of her integrated PCOS protocol.
The cluster of high triglycerides, low HDL, abdominal obesity, and elevated glucose signals deep metabolic dysfunction. Dr. Kallas Chemaly treats metabolic syndrome as a unified condition, not separate problems.
If your cholesterol or triglycerides are elevated — especially alongside another hormonal condition — an endocrinology assessment may change your management completely.
Book Online Consultation